Finch Therapeutics Group, Inc. Quarterly Operating Margin in % from Q4 2020 to Q4 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Finch Therapeutics Group, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q4 2023.
  • Finch Therapeutics Group, Inc. Operating Margin for the quarter ending December 31, 2023 was -78.4K %, a 484% decline year-over-year.
  • Finch Therapeutics Group, Inc. annual Operating Margin for 2023 was -78.4K %, a 484% decline from 2022.
  • Finch Therapeutics Group, Inc. annual Operating Margin for 2022 was -13.4K %, a 4048% decline from 2021.
  • Finch Therapeutics Group, Inc. annual Operating Margin for 2021 was -324 %, a 36.6% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -78.4K -64.9K -484% Oct 1, 2023 Dec 31, 2023
Q3 2023 -93.2K -86.8K -1347% Jul 1, 2023 Sep 30, 2023
Q2 2023 -56.9K -56.3K -9511% Apr 1, 2023 Jun 30, 2023
Q1 2023 -25.5K -25.1K -5447% Jan 1, 2023 Mar 31, 2023
Q4 2022 -13.4K -13.1K -4048% Oct 1, 2022 Dec 31, 2022
Q3 2022 -6.44K -6.17K -2229% Jul 1, 2022 Sep 30, 2022
Q2 2022 -592 -48.2 -8.86% Apr 1, 2022 Jun 30, 2022
Q1 2022 -460 +20.1 +4.18% Jan 1, 2022 Mar 31, 2022
Q4 2021 -324 +187 +36.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -277 Jul 1, 2021 Sep 30, 2021
Q2 2021 -544 Apr 1, 2021 Jun 30, 2021
Q1 2021 -480 Jan 1, 2021 Mar 31, 2021
Q4 2020 -511 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.